- Investor's Business Daily•20 hours ago
European, Japanese or specialty pharma could look to acquire Ariad as it rapidly closes in on approval of a lung cancer drug, RBC says.
- Investor's Business Daily•2 days ago
Sanofi is mulling a bid for Actelion, which has an offer from Johnson & Johnson on the table.
- Zacks•2 days ago
Roche Holding AG (RHHBY) announced encouraging data from the pivotal phase III study, GALLIUM.
RHHBY : Summary for ROCHE HLDGS AG SPN ADR EACH REP - Yahoo Finance
Roche Holding AG (RHHBY)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||25.25 - 27.26|
|52 Week Range||25.25 - 35.13|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||20.89|
|Dividend & Yield||1.02 (3.68%)|
|1y Target Est||N/A|